S&P 500   3,116.39 (-0.38%)
DOW   26,957.59 (-0.46%)
QQQ   216.48 (+0.52%)
AAPL   292.65 (+1.59%)
FB   197.20 (+0.22%)
MSFT   170.17 (+1.25%)
GOOGL   1,390.47 (+0.30%)
AMZN   1,979.59 (+0.35%)
CGC   19.82 (+1.02%)
NVDA   267.65 (+2.14%)
BABA   208.74 (+1.52%)
MU   52.37 (+0.52%)
GE   10.95 (-3.27%)
TSLA   778.80 (-2.64%)
AMD   47.49 (-0.17%)
T   37.10 (-0.67%)
ACB   1.51 (+0.00%)
F   7.21 (-0.28%)
NFLX   379.24 (+5.32%)
PRI   120.14 (-1.05%)
BAC   30.63 (-1.45%)
DIS   123.36 (-3.77%)
GILD   74.70 (+6.56%)
S&P 500   3,116.39 (-0.38%)
DOW   26,957.59 (-0.46%)
QQQ   216.48 (+0.52%)
AAPL   292.65 (+1.59%)
FB   197.20 (+0.22%)
MSFT   170.17 (+1.25%)
GOOGL   1,390.47 (+0.30%)
AMZN   1,979.59 (+0.35%)
CGC   19.82 (+1.02%)
NVDA   267.65 (+2.14%)
BABA   208.74 (+1.52%)
MU   52.37 (+0.52%)
GE   10.95 (-3.27%)
TSLA   778.80 (-2.64%)
AMD   47.49 (-0.17%)
T   37.10 (-0.67%)
ACB   1.51 (+0.00%)
F   7.21 (-0.28%)
NFLX   379.24 (+5.32%)
PRI   120.14 (-1.05%)
BAC   30.63 (-1.45%)
DIS   123.36 (-3.77%)
GILD   74.70 (+6.56%)
S&P 500   3,116.39 (-0.38%)
DOW   26,957.59 (-0.46%)
QQQ   216.48 (+0.52%)
AAPL   292.65 (+1.59%)
FB   197.20 (+0.22%)
MSFT   170.17 (+1.25%)
GOOGL   1,390.47 (+0.30%)
AMZN   1,979.59 (+0.35%)
CGC   19.82 (+1.02%)
NVDA   267.65 (+2.14%)
BABA   208.74 (+1.52%)
MU   52.37 (+0.52%)
GE   10.95 (-3.27%)
TSLA   778.80 (-2.64%)
AMD   47.49 (-0.17%)
T   37.10 (-0.67%)
ACB   1.51 (+0.00%)
F   7.21 (-0.28%)
NFLX   379.24 (+5.32%)
PRI   120.14 (-1.05%)
BAC   30.63 (-1.45%)
DIS   123.36 (-3.77%)
GILD   74.70 (+6.56%)
S&P 500   3,116.39 (-0.38%)
DOW   26,957.59 (-0.46%)
QQQ   216.48 (+0.52%)
AAPL   292.65 (+1.59%)
FB   197.20 (+0.22%)
MSFT   170.17 (+1.25%)
GOOGL   1,390.47 (+0.30%)
AMZN   1,979.59 (+0.35%)
CGC   19.82 (+1.02%)
NVDA   267.65 (+2.14%)
BABA   208.74 (+1.52%)
MU   52.37 (+0.52%)
GE   10.95 (-3.27%)
TSLA   778.80 (-2.64%)
AMD   47.49 (-0.17%)
T   37.10 (-0.67%)
ACB   1.51 (+0.00%)
F   7.21 (-0.28%)
NFLX   379.24 (+5.32%)
PRI   120.14 (-1.05%)
BAC   30.63 (-1.45%)
DIS   123.36 (-3.77%)
GILD   74.70 (+6.56%)
Log in

NASDAQ:ENDP - Endo International Stock Price, Forecast & News

$6.35
-0.18 (-2.76 %)
(As of 02/26/2020 04:00 PM ET)
Today's Range
$5.85
Now: $6.35
$6.58
50-Day Range
$4.36
MA: $5.86
$6.60
52-Week Range
$1.97
Now: $6.35
$12.49
Volume9.68 million shs
Average Volume7.21 million shs
Market Capitalization$1.44 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.48
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. The company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals, and International Pharmaceuticals. The U.S. Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, abuse-deterrent products, liquids, semi-solids, patches, powders, ophthalmics, sprays, and sterile injectables, as well as products for the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and cardiovascular disease markets. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
Current SymbolNASDAQ:ENDP
CUSIP29264F20
Phone011-353-1268-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.95 billion
Cash Flow$6.61 per share
Book Value($2.22) per share

Profitability

Net Income$-1,031,470,000.00

Miscellaneous

Employees2,910
Market Cap$1.44 billion
Next Earnings Date2/26/2020 (Confirmed)
OptionableOptionable

Receive ENDP News and Ratings via Email

Sign-up to receive the latest news and ratings for ENDP and its competitors with MarketBeat's FREE daily newsletter.


Endo International (NASDAQ:ENDP) Frequently Asked Questions

What is Endo International's stock symbol?

Endo International trades on the NASDAQ under the ticker symbol "ENDP."

How were Endo International's earnings last quarter?

Endo International PLC (NASDAQ:ENDP) announced its earnings results on Wednesday, February, 26th. The company reported $0.74 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.57 by $0.17. The firm earned $764.80 million during the quarter, compared to analysts' expectations of $730.15 million. Endo International had a negative return on equity of 99.08% and a negative net margin of 16.89%. The business's revenue was down 2.7% on a year-over-year basis. During the same period in the prior year, the firm earned $0.75 EPS. View Endo International's Earnings History.

When is Endo International's next earnings date?

Endo International is scheduled to release their next quarterly earnings announcement on Wednesday, February 26th 2020. View Earnings Estimates for Endo International.

What guidance has Endo International issued on next quarter's earnings?

Endo International issued an update on its FY20 earnings guidance on Wednesday, February, 26th. The company provided EPS guidance of $2.15-2.40 for the period, compared to the Thomson Reuters consensus estimate of $2.25. The company issued revenue guidance of $2.72-2.92 billion, compared to the consensus revenue estimate of $2.90 billion.

What price target have analysts set for ENDP?

13 Wall Street analysts have issued twelve-month price targets for Endo International's shares. Their forecasts range from $2.00 to $15.00. On average, they expect Endo International's share price to reach $7.38 in the next year. This suggests a possible upside of 16.1% from the stock's current price. View Analyst Price Targets for Endo International.

What is the consensus analysts' recommendation for Endo International?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Endo International in the last year. There are currently 2 sell ratings, 8 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Endo International.

Has Endo International been receiving favorable news coverage?

News coverage about ENDP stock has been trending somewhat negative on Wednesday, according to InfoTrie Sentiment. The research group identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Endo International earned a media sentiment score of -1.2 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for Endo International.

Who are some of Endo International's key competitors?

What other stocks do shareholders of Endo International own?

Who are Endo International's key executives?

Endo International's management team includes the folowing people:
  • Mr. Paul V. Campanelli, Pres, CEO & Director (Age 57)
  • Mr. Blaise Coleman, Exec. VP & CFO (Age 45)
  • Mr. Terrance J. Coughlin, Exec. VP & COO (Age 53)
  • Mr. Matthew Joseph Maletta, Exec. VP & Chief Legal Officer (Age 47)
  • Mr. Antonio R. Pera, Pres of Par Pharmaceutical (Age 62)

Who are Endo International's major shareholders?

Endo International's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Geode Capital Management LLC (1.41%), Bank of New York Mellon Corp (1.05%), Connor Clark & Lunn Investment Management Ltd. (0.45%), Rhumbline Advisers (0.26%), New York State Teachers Retirement System (0.14%) and New York State Common Retirement Fund (0.09%). Company insiders that own Endo International stock include Nancy J Hutson, Roger H Kimmel and William P Montague. View Institutional Ownership Trends for Endo International.

Which institutional investors are selling Endo International stock?

ENDP stock was sold by a variety of institutional investors in the last quarter, including Diamond Hill Capital Management Inc., Panagora Asset Management Inc., Connor Clark & Lunn Investment Management Ltd., Pinebridge Investments L.P., Arizona State Retirement System, UBS Asset Management Americas Inc., Nisa Investment Advisors LLC and Mitsubishi UFJ Trust & Banking Corp. View Insider Buying and Selling for Endo International.

Which institutional investors are buying Endo International stock?

ENDP stock was bought by a variety of institutional investors in the last quarter, including Dupont Capital Management Corp, Geode Capital Management LLC, Rhumbline Advisers, Sowell Financial Services LLC, 361 Capital LLC and Bank of New York Mellon Corp. View Insider Buying and Selling for Endo International.

How do I buy shares of Endo International?

Shares of ENDP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Endo International's stock price today?

One share of ENDP stock can currently be purchased for approximately $6.35.

How big of a company is Endo International?

Endo International has a market capitalization of $1.44 billion and generates $2.95 billion in revenue each year. The company earns $-1,031,470,000.00 in net income (profit) each year or $2.89 on an earnings per share basis. Endo International employs 2,910 workers across the globe.View Additional Information About Endo International.

What is Endo International's official website?

The official website for Endo International is http://www.endo.com/.

How can I contact Endo International?

Endo International's mailing address is First Floor Minerva House Simmonscourt Road Ballsbridge, Dublin L2, 19355. The company can be reached via phone at 011-353-1268-2000 or via email at [email protected]


MarketBeat Community Rating for Endo International (NASDAQ ENDP)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  901 (Vote Outperform)
Underperform Votes:  792 (Vote Underperform)
Total Votes:  1,693
MarketBeat's community ratings are surveys of what our community members think about Endo International and other stocks. Vote "Outperform" if you believe ENDP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ENDP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel